Exercise Intolerance in Adult Congenital Heart Disease: Comparative Severity, Correlates, and Prognostic Implication

Background—Although some patients with adult congenital heart disease (ACHD) report limitations in exercise capacity, we hypothesized that depressed exercise capacity may be more widespread than superficially evident during clinical consultation and could be a means of assessing risk. Methods and Results—Cardiopulmonary exercise testing was performed in 335 consecutive ACHD patients (age, 33±13 years), 40 non–congenital heart failure patients (age, 58±15 years), and 11 young (age, 29±5 years) and 12 older (age, 59±9 years) healthy subjects. Peak oxygen consumption (peak &OV0312;o2) was reduced in ACHD patients compared with healthy subjects of similar age (21.7±8.5 versus 45.1±8.6; P<0.001). No significant difference in peak &OV0312;o2 was found between ACHD and heart failure patients of corresponding NYHA class (P=NS for each NYHA class). Within ACHD subgroups, peak &OV0312;o2 gradually declined from aortic coarctation (28.7±10.4) to Eisenmenger (11.5±3.6) patients (P<0.001). Multivariable correlates of peak &OV0312;o2 were peak heart rate (r=0.33), forced expiratory volume (r=0.33), pulmonary hypertension (r=−0.26), gender (r=−0.23), and body mass index (r=−0.19). After a median follow-up of 10 months, 62 patients (18.5%) were hospitalized or had died. On multivariable Cox analysis, peak &OV0312;o2 predicted hospitalization or death (hazard ratio, 0.937; P=0.01) and was related to the frequency and duration of hospitalization (P=0.01 for each). Conclusions—Exercise capacity is depressed in ACHD patients (even in allegedly asymptomatic patients) on a par with chronic heart failure subjects. Lack of heart rate response to exercise, pulmonary arterial hypertension, and impaired pulmonary function are important correlates of exercise capacity, as is underlying cardiac anatomy. Poor exercise capacity identifies ACHD patients at risk for hospitalization or death.

[1]  A. Torbicki,et al.  Guidelines on diagnosis and treatment of pulmonary arterial hypertension , 2004 .

[2]  Horst Olschewski,et al.  Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. , 2004, European heart journal.

[3]  J. Myers,et al.  Predictors of exercise capacity and the impact of angiographic coronary artery disease in heart transplant recipients. , 2004, American heart journal.

[4]  S. Gläser,et al.  Assessment of symptoms and exercise capacity in cyanotic patients with congenital heart disease. , 2004, Chest.

[5]  B. Zrenner,et al.  Emergency hospital admissions and three-year survival of adults with and without cardiovascular surgery for congenital cardiac disease. , 2003, The Journal of thoracic and cardiovascular surgery.

[6]  G. Veldtman,et al.  Aerobic capacity in adults with tetralogy of Fallot , 2002, Cardiology in the Young.

[7]  M. Juneau,et al.  Improvement in Exercise Capacity in Asymptomatic and Mildly Symptomatic Adults After Atrial Septal Defect Percutaneous Closure , 2002, Circulation.

[8]  S. Anker,et al.  Neurohormonal Activation and the Chronic Heart Failure Syndrome in Adults With Congenital Heart Disease , 2002, Circulation.

[9]  S. De Geest,et al.  A pilot study of expenditures on, and utilization of resources in, health care in adults with congenital heart disease , 2001, Cardiology in the Young.

[10]  Geoffrey I. Webb,et al.  Lung function and aerobic capacity in adult patients following modified Fontan procedure , 2001, Heart.

[11]  Geoffrey I. Webb,et al.  Aerobic capacity in adults with various congenital heart diseases. , 2001, The American journal of cardiology.

[12]  G. Veldtman,et al.  Exercise capacity in adult patients with congenitally corrected transposition of the great arteries , 2001, Heart.

[13]  S. Siu,et al.  Cardiopulmonary exercise performance in adult survivors of the Mustard procedure , 2000, Cardiology in the Young.

[14]  V. Boddi,et al.  Comparison of different methods of functional evaluation in patients with chronic heart failure , 2000, European journal of heart failure.

[15]  A. Coats,et al.  Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2)slope and peak VO(2). , 2000, European heart journal.

[16]  Geoffrey I. Webb,et al.  Cardiopulmonary function in adult patients late after Fontan repair. , 1995, Journal of the American College of Cardiology.

[17]  M. Gatzoulis,et al.  Right ventricular diastolic function 15 to 35 years after repair of tetralogy of Fallot. Restrictive physiology predicts superior exercise performance. , 1995, Circulation.

[18]  F. Tristani,et al.  Ejection Fraction, Peak Exercise Oxygen Consumption, Cardiothoracic Ratio, Ventricular Arrhythmias, and Plasma Norepinephrine as Determinants of Prognosis in Heart Failure , 1993, Circulation.

[19]  A. Nogami,et al.  Anaerobic metabolism as an indicator of aerobic function during exercise in cardiac patients. , 1992, Journal of the American College of Cardiology.

[20]  A. Koike,et al.  Evaluation of severity of heart failure using ventilatory gas analysis. , 1990, Circulation.

[21]  D. Lipkin,et al.  The role of exercise testing in chronic heart failure. , 1987, British heart journal.